Listen to Our Podcasts

Save as Favorite
Sign in to receive recommendations (Learn more)
Filter by Category

Filter by Month
Filter by Year

HER2-Positive Breast Cancer Recurrence Marleen Meyers, M.D.

December 15, 2017

Meyers marleen

Dr. Marleen Meyers is a medical oncologist and clinical assistant professor of medicine at NYU Langone. She also serves as director of the Perlmutter Cancer Center Survivorship Program. She received her medical degree from the NYU School of Medicine and has been in practice for more than 20 years.

Listen to the podcast to hear Dr. Meyers talk about:

  • what HER2-positive breast cancer is and how its aggressiveness ranks compared to other types of breast cancer
  • factors doctors consider when estimating a person’s risk of recurrence
  • specific ways to reduce the risk of HER2-positive disease recurrence
  • how she helps her patients manage the fear of recurrence

Running time: 17:06

Ovarian Suppression Can Help Protect Ovarian Function and May Preserve Fertility in Younger Women Being Treated with Chemotherapy Matteo Lambertini, M.D.

December 8, 2017

Lambertini matteo

Preserving fertility after chemotherapy is an important issue for many, many younger women diagnosed with early-stage breast cancer. Dr. Matteo Lambertini, medical oncologist at the Institute Jules Bordet Brussels, presented research at the 2017 San Antonio Breast Cancer Symposium showing that ovarian suppression with a gonadotropin-releasing hormone analogue such as Lupron, Trelstar, or Zoladex, can safely protect ovarian function and may help preserve fertility in younger women being treated with chemotherapy for early-stage disease.

Listen to the podcast to hear Dr. Lambertini explain:

  • why earlier studies on this topic had mixed results
  • the results of the study
  • the side effects of gonadotropin-releasing hormone analogues
  • the strategies he recommends to his younger patients diagnosed with early-stage breast cancer who want to have a child after chemotherapy

Running time: 9:09

Postmenopausal Women Who Lose Modest Amount of Weight Have Lower Breast Cancer Risk Rowan Chlebowski, M.D., Ph.D.

December 8, 2017

Chlebowski rowan

Research has shown that women who are overweight or obese have a higher risk of breast cancer, especially after menopause. Still, research results have been mixed on whether losing weight would decrease a postmenopausal woman's breast cancer risk. Rowan Chlebowski, research professor in the Department of Medical Oncology and Therapeutics Research at City of Hope, discusses an analysis of data from the very large Women's Health Initiative Observational Study that found that overweight or obese postmenopausal women who lost just a modest amount of weight -- as little as 10 or 15 pounds -- had a lower risk of breast cancer.

Listen to the podcast to hear Dr. Chlebowski explain:

  • why he wanted to do this study
  • why this study was different than earlier studies
  • his advice to postmenopausal women

Running time: 7:48

Acupuncture Helps Ease Joint Pain Caused by Aromatase Inhibitors Dawn Hershman, M.D.

December 8, 2017

Hershman dawn

Joint pain is one of the most common side effects of aromatase inhibitors and may be a big reason why women stop taking these medicines early. Dr. Dawn Hershman, leader of the Breast Cancer Program at the Herbert Irving Comprehensive Cancer Center at New York-Presbyterian/Columbia University Medical Center, presented research at the 2017 San Antonio Breast Cancer Symposium showing that acupuncture can ease aromatase inhibitor-caused joint pain, even after the acupuncture treatment sessions stop.

Listen to the podcast to hear Dr. Hershman explain:

  • how much acupuncture eases joint pain
  • why she believes acupuncture could help many women stick to their hormonal therapy treatment plans
  • the cost of acupuncture relative to other treatments
  • the few and mild side effects of acupuncture

Running time: 13:26

Experimental Talazoparib Seems Better Than Chemotherapy for Metastatic HER2-Negative Disease in Women With a BRCA Mutation Jennifer Litton, M.D.

December 8, 2017

Litton jennifer

Jennifer Litton, associate professor of breast Medical Oncology at the University of Texas MD Anderson Cancer Center, discusses the results of the EMBRACA study she presented at the 2017 San Antonio Breast Cancer Symposium showing that talazoparib, an experimental targeted therapy medicine, improved the time until the cancer grew in women with a BRCA1 or BRCA2 mutation who had been diagnosed with metastatic HER2-negative breast cancer compared to chemotherapy.

Listen to the podcast to hear Dr. Litton explain:

  • how talazoparib works
  • whether talazoparib will offer benefits to women with other mutations linked to a higher risk of breast cancer
  • how the side effects differed between talazoparib and chemotherapy
  • why quality of life was better in women who were treated with talazoparib

Running time: 9:58

Raising Awareness of Inflammatory Breast Cancer -- Heard in the Halls: Voices from the 2017 San Antonio Breast Cancer Symposium Terry Lynn Arnold

December 7, 2017

Terry arnold

Terry Lynn Arnold, founder of The IBC Network Foundation who was diagnosed with triple-negative inflammatory breast cancer in 2007, talks about how her organization is raising awareness of and funding research on this rare type of breast cancer.

Running time: 1:48

The Serenity Project: This Is Metastatic Breast Cancer -- Heard in the Halls: Voices from the 2017 San Antonio Breast Cancer Symposium Kelly Shanahan, M.D.

December 7, 2017

Kelly shanahan %282%29

Kelly Shanahan, MD, a former obstetrician/gynecologist, was diagnosed with early-stage breast cancer in 2008 and then diagnosed with metastatic disease in 2013, on her birthday. Here she talks about how empowering it was to participate in the #ThisIsMBC Serenity Project, which gives women and men living with metastatic breast cancer an opportunity to tell their personal stories through a series of unique pictures and inspiring videos.

Running time: 4:01

The Metastatic Breast Cancer Alliance: Looking Forward -- Heard in the Halls: Voices from the 2017 San Antonio Breast Cancer Symposium Marc Hurlbert

December 6, 2017

Hurlbert

Marc Hurlbert, chairperson of the Metastatic Breast Cancer Alliance (MBCA) and chief mission officer of the Breast Cancer Research Foundation, discusses some research presented in San Antonio by MBCA collaborators.

Running time: 3:00

Kisqali in Combination with Hormonal Therapy and Ovarian Suppression Effective Treatment for Metastatic Hormone-Receptor-Positive, HER2-Negative Disease in Premenopausal Women: 2017 SABCS Debu Tripathy, M.D.

December 6, 2017

Debu tripathy headshot

The targeted therapy Kisqali (chemical name: ribociclib) is approved to be used in combination with an aromatase inhibitor to treat advanced-stage or metastatic hormone-receptor-positive, HER2-negative breast cancer that hasn’t been treated with hormonal therapy yet in postmenopausal women. Dr. Debu Tripathy, professor of medicine and chairperson of the Department of Breast Medical Oncology at the University of Texas MD Anderson Cancer Center, discusses the results of the MONALEESA-7 study he presented at the 2017 San Antonio Breast Cancer Symposium showing that Kisqali can help treat premenopausal and perimenopausal women diagnosed with the same type of breast cancer.

Listen to the podcast to hear Dr. Tripathy explain:

  • why the study is important
  • why ovarian suppression helps make the treatments more effective
  • the side effects caused by Kisqali
  • why he thinks this study will change practice

Running time: 7:25

Where Are We With Immunotherapy to Treat Breast Cancer? -- Heard in the Halls: Voices from the 2017 San Antonio Breast Cancer Symposium Leisha Emens, M.D., Ph.D.

December 5, 2017

Emens headshot

Leisha Emens, associate professor of oncology at Johns Hopkins University School of Medicine and member of the Bloomberg~Kimmel Institute for Cancer Immunotherapy, discusses the state of immunotherapy to treat breast cancer.

Running time: 3:15

Stories of Mastectomy and Reconstruction: Peggy Peggy Johnson

October 18, 2017

Peggy headshot

A former first grade teacher, Peggy Johnson was diagnosed with breast cancer in November 2009 after she became concerned about some dimpling in her left breast. She had six rounds of chemotherapy, then a double mastectomy with immediate implant reconstruction in May 2010. She then had radiation therapy. After that treatment was completed, she had new implants inserted in December 2010. At that time, nipple reconstruction wasn’t offered to her. In early 2016, at her annual exam with her breast surgeon, the surgeon discovered that one of her implants had ruptured and was leaking. Peggy was told she would have to have her implants replaced yet again. Instead, she decided to have DIEP flap reconstruction as well as nipple reconstruction and nipple tattooing in May 2016.

Peggy is one of three women whose stories are featured in the Breastcancer.org video series on reconstruction after mastectomy.

Listen to the podcast to hear Peggy talk about:

  • why she decided to have DIEP flap surgery when her implant ruptured
  • how keeping a journal helped her
  • how she tries to be a resource for women diagnosed with breast cancer

Running time: 17:43

Stories of Mastectomy and Reconstruction: Mimi Mimi Monteiro

October 5, 2017

Mimi headshot

Breast cancer was familiar to Mimi, even before she was diagnosed. Her mother has been diagnosed with breast cancer three times. She was treated with a double mastectomy, radiation and chemotherapy. Fifteen years later, she is cancer-free. Mimi’s cousin Annette, her best friend, was diagnosed with breast cancer in 2009 and passed away from the disease that same year at age 42. Mimi herself was diagnosed with stage I breast cancer in April 2015 at age 45, the same age her mother was first diagnosed. She had a double mastectomy with immediate DIEP flap reconstruction. Later she also had a preventive hysterectomy because the cancer was hormone-receptor-positive. She took tamoxifen and an aromatase inhibitor but has since stopped.

Mimi is one of three women whose stories are featured in the Breastcancer.org video series on reconstruction after mastectomy.

Listen to the podcast to hear Mimi discuss:

  • how she made her decisions about surgery and reconstruction
  • the positives she believes breast cancer brought to her life
  • what she would say to a woman who was recently diagnosed with breast cancer

Running time: 16:51

Stories of Mastectomy and Reconstruction: Deidra Deidra Langridge

October 2, 2017

Deidra headshot

A former pharmaceutical sales rep, Deidra is a 3-time cancer survivor. She was diagnosed with melanoma in 1991 at age 32 in 1991. In 2006, she was diagnosed with non-Hodgkin lymphoma at age 47. Three days before Christmas in 2014 and 12 weeks before the wedding of her son, Pierce, she was diagnosed with hormone-receptor-positive breast cancer in two spots. She had double mastectomy and immediate DIEP flap reconstruction on January 18. She also had nipple reconstruction and tattooing. Her goal was to be able to dance at Pierce’s wedding, and she did. She continues to take an aromatase inhibitor.

Deidra is one of three women whose stories are featured in the Breastcancer.org video series on reconstruction after mastectomy.

Listen to the podcast to hear Deidra talk about:

  • why she was honored to share her story
  • what she would tell a woman who was recently diagnosed with breast cancer
  • how she felt when she was relating her story on camera
  • what dancing at Pierce’s wedding meant to her

Running time: 20:17

Metastatic Breast Cancer: Now What? Krista Curley

September 22, 2017

Krista curley headshot

Krista Curley was diagnosed 3 1/2 years ago with estrogen-receptor-positive metastatic breast cancer in her lymph system and bones at the age of 39. She had no previous diagnosis of cancer. Since her initial diagnosis, the cancer has spread further into her bones and to her liver, despite surgery, various hormonal therapies, and chemotherapy. Krista lives in Ontario, Canada and is married to Patrick, the love of her life. She is the mother of Ethan, who is 16, and Naomi, who is 10. She has a blog about living with metastatic disease called “Metastatic Breast Cancer: Now What?

Listen to the podcast to hear Krista talk about:

  • what writing the blog gives to her
  • how she and her family find joy and humor in day-to-day life
  • how she talked to her kids about metastatic disease
  • the one thing she would tell people about metastatic breast cancer

Running time: 25:20

Nipple Reconstruction Frank DellaCroce, M.D., F.A.C.S.

September 21, 2017

Dellacroce suit

Dr. Frank DellaCroce, or "Dr. D" as he has come to be known, is a founding partner of the Center for Restorative Breast Surgery and St. Charles Surgical Hospital in New Orleans. Board-certified in plastic surgery, Dr. D has performed thousands of reconstructive procedures, both for women diagnosed with breast cancer and women at high risk of the disease who choose to have prophylactic breast removal. He is a fellow of the American College of Surgeons and a member of numerous professional societies, including the American Society of Plastic and Reconstructive Surgery, the American Society for Reconstructive Microsurgery, and the World Society for Reconstructive Microsurgery. He also has been named one of the “Best Doctors in America.”

Listen to the podcast to hear Dr. D discuss:

  • the benefits and risks of nipple reconstruction
  • the timing of nipple reconstruction
  • how nipple reconstruction has evolved over the years
  • how long the procedure takes and what recovery is like

Running time: 18:06

Facing the End of Life Kelly Grosklags, LICSW, BCD

July 31, 2017

Grosklags kelly

For nearly 25 years, Kelly Grosklags has dedicated her practice to minimizing suffering through her work in oncology, palliative care and hospice. An experienced therapist, Kelly is a licensed clinical social worker and a board-certified diplomat in clinical social work. She also earned a fellowship in grief counseling from the American Academy of Health Care Professionals. Kelly speaks frequently about end-of-life issues, including care, grief and loss, both in person and on her website, Conversations With Kelly. Her passionate and supportive demeanor helps patients, caregivers and health professionals connect with the wisdom of making life more meaningful, coping with depression and anxiety, transforming fear into hope, healing versus curing, and the wisdom of dying a good death.

Listen to the podcast to hear Kelly talk about:

  • becoming comfortable with talking about the end of life
  • why stopping treatment is not giving up
  • hospice care -- what it is and when to start talking about it
  • how to talk to children about the end of life

Running time: 34:05

Photo: Geordie Griffiths

Controlling Pain During and After Breast Cancer Surgery Beth Baughman DuPree, M.D., F.A.C.S., A.B.I.H.M.

July 24, 2017

Beth dupree

Beth Baughman DuPree performs breast cancer surgery and is vice president at the Holy Redeemer Health System, as well as an adjunct assistant professor of surgery at the University of Pennsylvania. She is a board certified general surgeon specializing in diseases of the breast. She also has obtained dual board certification in integrative and holistic medicine. She has won numerous awards for her medical work as well as her humanitarian endeavors. Dr. DuPree’s skin-sparing mastectomies, performed in conjunction with plastic surgeon Robert Skalicky, were featured live on the Internet; the webcast and subsequent documentary received a Gracie Award.

Listen to the podcast to hear Dr. DuPree discuss:

  • the types of medicines used to control pain during breast cancer surgery
  • non-opioid pain control options for people in recovery or who simply don’t want an opioid
  • the side effects of pain medications
  • ways to control pain that don’t involve medication

Running time: 23:11

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Managing the Emotions of Metastatic Breast Cancer Kelly Grosklags, LICSW, BCD

July 14, 2017

Grosklags kelly

For nearly 25 years, Kelly Grosklags has dedicated her practice to minimizing suffering through her work in oncology, palliative care and hospice. An experienced therapist, Kelly is a licensed clinical social worker and a board-certified diplomat in clinical social work. She also earned a fellowship in grief counseling from the American Academy of Health Care Professionals. Kelly speaks frequently about end-of-life issues, including care, grief and loss, both in person and on her website, Conversations With Kelly. Her passionate and supportive demeanor helps patients, caregivers and health professionals connect with the wisdom of making life more meaningful, coping with depression and anxiety, transforming fear into hope, healing versus curing, and the wisdom of dying a good death.

Listen to the podcast to hear Kelly talk about:

  • taming the feelings of fear, anger, and loss of control that can come with a metastatic diagnosis
  • strategies to deal with “scanxiety”
  • how to allow yourself to ask for help
  • how and how much to disclose about your diagnosis to your friends and at work

Running time: 46:06

Photo: Geordie Griffiths

Personal Finance After a Breast Cancer Diagnosis: Advice From Suze Orman Suze Orman

June 26, 2017

Suze orman small

Suze Orman has been called “a force in the world of personal finance” and a “one-woman financial advice powerhouse” by USA Today. A two-time Emmy Award-winning television host, New York Times mega bestselling author, magazine and online columnist, writer/producer, and one of the top motivational speakers in the world today, Orman is undeniably America’s most recognized expert on personal finance.

Listen to the podcast to hear Suze discuss:

  • the four documents that EVERYONE should have
  • what a young parent with metastatic disease can do protect the financial future of her minor children
  • when to start taking disability or Social Security payments if you’ve been diagnosed with stage IV breast cancer
  • the differences between wills and trusts

Running time: 30:44

Living Well With Metastatic Disease: Controlling Fear, Finding Joy Teva Harrison

May 30, 2017

Teva harrison pic

Teva Harrison is an artist, writer, and cartoonist who was diagnosed with stage IV breast cancer at age 37. She is the author of the bestselling, critically acclaimed graphic memoir, In-Between Days; the book was shortlisted for the Governor General's Literary Award for Non-Fiction.

Teva is a Canadian Magazine Award and National Magazine Award finalist whose writing and/or comics have appeared in The Walrus, Quill & Quire, Huffington Post, Carte Blanche, The Humber Literary Review, The Globe and Mail, and more. She is a regular commentator on radio, television, and in newspapers, including CBC Radio, the Toronto Star, The Globe and Mail, and The Agenda with Steve Paikin.

Born and raised in rural Oregon, Teva currently lives in Toronto with her husband.

Listen to the podcast to hear Teva talk about:

  • how she changed her mind about being public about her diagnosis
  • how she controls her fear and finds joy and beauty in her life
  • the things she’s saying yes to and how they are making her happy
  • what leaving a legacy means to her

Running time: 25:09

Pausing Hormonal Therapy Treatment to Have a Child: The POSITIVE Trial Ann Partridge, M.D., M.P.H.

March 24, 2017

Partridge ann

Ann Partridge, M.D., MPH., is founder and director of the Program for Young Women with Breast Cancer and the Adult Survivorship Program, as well as senior physician at the Dana-Farber Cancer Institute and associate professor of medicine at Harvard Medical School. She is a medical oncologist focusing on the care of women with breast cancer and has a particular interest in the psychosocial, behavioral and communication issues in breast cancer care and treatment.

Dr. Partridge is also the lead investigator of the U.S. arm of the POSITIVE trial. This study is looking at whether premenopausal women diagnosed with hormone-receptor-positive disease who stop taking hormonal therapy after about 1.5 to 2.5 years of treatment to get pregnant have a higher risk of the breast cancer coming back, which doctors call recurrence. Most women diagnosed with hormone receptor positive disease take hormonal therapy for 5 to 10 years after surgery. In the POSITIVE trial, the women who want to get pregnant are stopping hormonal therapy for up to 2 years to become pregnant, deliver the baby and breastfeed. The women then start hormonal therapy again.

Listen to the podcast to hear Dr. Partridge talk about:

  • why the researchers decided to do this study
  • the safeguards the study has in place so a developing baby won’t be harmed by the hormonal therapy medicine
  • other safety concerns associated with stopping hormonal therapy to get pregnant besides recurrence risk

The POSITIVE trial is currently recruiting participants. If you are a premenopausal woman who has been diagnosed with hormone-receptor-positive breast cancer and have been taking hormonal therapy medicine for fewer than 2 years and are interested in participating in the study, visit the ClinicalTrials.gov page for complete details. You also can call Dr. Partridge’s office at the Dana-Farber Cancer Center at 617-632-3800 to discuss participating in the study.

Running time: 27:09

Visit the Fertility and Pregnancy Issues During and After Breast Cancer section for more information on pregnancy after treatment.


These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations from listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of people who depend on us.

Biosimilars: What Are They and What Are Their Advantages? Philip Lammers, M.D., M.S.C.I.

March 8, 2017

Lammers philip

Dr. Philip Lammers, a medical oncologist, is the chief of the Division of Hematology/Oncology at Meharry Medical College and adjunct assistant professor of internal medicine at Vanderbilt University. He has several active research projects on ways to increase minority and underserved population representation in clinical trials. He also studies state-of-the art cancer treatments, including biosimilars.

Listen to the podcast to hear Dr. Lammers explain:

  • what a biosimilar drug is, as well as the approval process for biosimilars
  • how we can be sure that biosimilars are as safe as the reference products
  • the advantages and disadvantages of biosimilars
  • when we might see biosimilars on the market to treat breast cancer

Running time: 15:10

Sexual Health, Intimacy, and Metastatic Disease: Reclaiming Your Sexual Self Sage Bolte, Ph.D., LCSW, OSW-C

February 10, 2017

Sage bolte

Sage Bolte is executive director of Life With Cancer and also serves as associate director of psychosocial program for the Inova Health System. She is an internationally recognized educator and speaker on sexual health, intimacy, and relationships among people diagnosed with cancer and other chronic diseases. She conducts lectures, workshops, and training to both patient and healthcare professional groups on the topic of the sexual self and cancer survivorship. Her goal is to help empower patients to reclaim their sexual selves in spite of the many physical and emotional changes they may experience from their cancer diagnosis and to help healthcare professionals feel more comfortable and knowledgeable to assess and address the sexual health needs of their patients.

Listen to the podcast to hear Sage talk about:

  • how women diagnosed with metastatic disease can redefine sexual health so they’re fulfilled and satisfied
  • tips for women who are having vaginal pain/dryness, including stretching and strengthening exercises
  • why it’s important to remember libido starts in the brain, not necessarily the body
  • how to start a conversation with a partner about what is pleasurable right now and how what’s desired may change

Running time: 26:33

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations from listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of people who depend on us.

Quality of Life With Metastatic Disease -- Heard in the Halls: Voices From the 2016 San Antonio Breast Cancer Symposium Leah Eshraghi

December 10, 2016

Eshraghi pic

Leah Eshraghi, director of clinical research at the Dr. Susan Love Research Foundation, discusses the poster she presented on quality of life and disease collateral damage in women diagnosed with metastatic breast cancer.

Running time: 3:05

Overcoming Hormonal Therapy Side Effects -- Heard in the Halls: Voices From the 2016 San Antonio Breast Cancer Symposium Marisa Weiss, M.D.

December 10, 2016

Marisa blog thumb

Breastcancer.org Chief Medical Officer and Founder Marisa Weiss, M.D. talks about the importance of sticking with a hormonal therapy treatment plan and ways to deal with any side effects.

Running time: 1:50

Radiation Effects on Reconstruction -- Heard in the Halls: Voices From the 2016 San Antonio Breast Cancer Symposium Marisa Weiss, M.D.

December 10, 2016

Marisa blog thumb

Breastcancer.org Chief Medical Officer and Founder Marisa Weiss, M.D. talks how radiation therapy can affect different types of breast reconstruction.

Running time: 4:28

Male Breast Cancer Advocacy -- Heard in the Halls: Voices From the 2016 San Antonio Breast Cancer Symposium Michael Singer

December 9, 2016

Singer michael small

"I've been on a roll of male breast cancer advocacy."

Breast cancer survivor Michael Singer was staffing the Male Breast Cancer Coalition booth at the 2016 San Antonio Breast Cancer Symposium. In this mini podcast, he talks about his diagnosis and how he works to raise awareness that men can be breast cancer patients, too.

Running time: 3:27

Experimental Buparlisib Offers Benefits, But Side Effects Too Toxic: 2016 San Antonio Breast Cancer Symposium Ruth O'Regan, M.D.

December 9, 2016

O regan ruth

The experimental medicine buparlisib helps treat metastatic hormone-receptor-positive, HER2-negative breast cancer that has been treated with an aromatase inhibitor, but grew after being treated with Afinitor (chemical name: everolimus) and Aromasin (chemical name: exemestane). In this podcast from the 2016 San Antonio Breast Cancer Symposium, Ruth O'Regan, M.D., professor of hematology and oncology at the University of Wisconsin and one of the researchers who did the phase III BELLE-3 trial, discusses the results of the study and explains why the mechanics of how buparlisib work are promising, even if buparlisib probably isn't the right medicine to treat breast cancer.

Listen to the podcast to hear Dr. O'Regan talk about:

  • how buparlisib works
  • why inhibiting the PI3 kinase pathway may help treat metastatic, hormone-receptor-positive disease that has stopped responding to hormonal therapy
  • buparlisib's unacceptable side effects
  • how she plans to talk to her patients about buparlisib

Running time: 5:04

Scalp Cooling -- Heard in the Halls: Voices From the 2016 San Antonio Breast Cancer Symposium Marisa Weiss, M.D.

December 9, 2016

Marisa blog thumb

Breastcancer.org Chief Medical Officer and Founder Marisa Weiss, M.D. offers her take on a new device that may help women keep quite a bit of their hair during chemotherapy.

Running time: 2:11

Liquid Tumor Biopsies -- Heard in the Halls: Voices From the 2016 San Antonio Breast Cancer Symposium Philomena McAndrew, M.D.

December 8, 2016

Philomena mcandrew2

"An exciting but early time."

Oncologist Philomena McAndrew talks about the exciting, but still early research on what's called by a variety of names: liquid tumor biopsies, circulating tumor cells, and cell free DNA and what the development of these tests might mean for patients in the future.

Running time: 1:59

New Scalp Cooling System Can Reduce Hair Loss From Chemotherapy: 2016 San Antonio Breast Cancer Symposium Julie Nangia, M.D.

December 8, 2016

Nangia headshot

Several studies have shown that cooling the scalp to a very low temperature can help reduce hair loss due to chemotherapy treatment for breast cancer. In this podcast, Julie Nangia, M.D., assistant professor of medicine, Baylor College of Medicine talks about the study results she presented at the 2016 San Antonio Breast Cancer Symposium on the Orbis Paxman Hair Loss Prevention System. The study was the first prospective, randomized trial on a scalp cooling system and found that about 50% of the women who used the cooling system kept most of their hair.

Listen to the podcast to hear Dr. Nangia explain:

  • how the Paxman Hair Loss Preservation System works
  • how the type of chemotherapy regimen the women were on affected the results
  • why doing a prospective, randomized trial was important

Running time: 9:54

Editor’s Note: On April 19, 2017, the Paxman Scalp Cooling System received U.S. Food and Drug Administration clearance. This means the system can be marketed in the United States.

Does 2.5 to 5 More Years of an Aromatase Inhibitor Offer Benefits? Maybe, For Some Women: 2016 San Antonio Breast Cancer Symposium Terry Mamounas, M.D., M.P.H.

December 7, 2016

Mamounas terry

In 2012, research results showed that taking the hormonal therapy tamoxifen for 10 years instead of 5 offered more benefits for women diagnosed with early-stage, hormone-receptor-positive breast cancer, including less recurrence and better overall survival. Since that time, researchers have wondered if extending the time a woman with early-stage, hormone-receptor-positive disease took an aromatase inhibitor would offer similar benefits.

In this podcast from the 2016 San Antonio Breast Cancer Symposium, Terry Mamounas, M.D., M.P.H., medical director of the University of Florida Health Cancer Center, discusses the results of his and other studies looking at whether 2.5 to 5 additional years of Femara (chemical name: letrozole) after 5 years of an aromatase inhibitor offered better survival or lowered the number of recurrences.

Listen to the podcast to hear Dr. Mamounas talk about:

  • the very specific group of women that may benefit from an additional 2.5 to 5 years of an aromatase inhibitor
  • which woman should not take an additional 2.5 to 5 years of an aromatase inhibitor
  • how women and their doctors can weigh the benefits and potential risks of extended aromatase inhibitor treatment
  • how he plans to talk to his patients about this issue

Running time: 9:09

Men Have Breasts, Too: Diagnosed With Male Breast Cancer Stephen Sala

November 2, 2016

Steve sala pic

In August 2016, Stephen Sala found a small lump on the right side of his chest. His doctor thought it was a cyst, but scheduled an ultrasound to be sure. His ultrasound results were concerning, so he had a mammogram the same day, followed a needle biopsy about a week later. The results showed breast cancer. He was 41. He decided to have a bilateral mastectomy to reduce his risk of contralateral disease; pathology results showed that he had cancer in his left chest as well. As he went through diagnosis and treatment, Steve experienced a number of awkward situations. Almost all mammography offices are in women’s health care centers, with no consideration for men. Forms asked when he had his last period, how many children he had given birth to, and if he was in menopause.

Listen to the podcast to hear Stephen talk about:

  • how he came to terms with a breast cancer diagnosis
  • his ideas on how the process can be made less clumsy for men
  • how he talked to his children about his diagnosis
  • how he found support
  • advice he would offer other men

Running time: 19:13

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations from listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of people who depend on us.

Stories of Genetic Testing, Prophylactic Surgery, and Reconstruction: Mandi Mandi Seifert

September 9, 2016

Mandi headshot

Mandi Seifert was 3 when her mother was diagnosed with breast cancer in 1990. When it became available, genetic testing for a mutation that raises the risk of breast cancer was strongly recommended for Mandi’s mom -- in 2010 her mother tested positive for a BRCA2 mutation. Mandi knew that meant she had a 50-50 chance of having the same mutation. In 2013, she decided to have genetic testing and learned that she, too, had a BRCA2 mutation. She decided to have a double prophylactic mastectomy and reconstruction using tissue from her tummy area. Mandi is one of three women whose stories are featured in the Breastcancer.org video series on genetic testing, prophylactic surgery, and reconstruction. Mandi’s older sister, Kerry, also tested positive for a BRCA2 mutation and is also in the video series.

Listen to the podcast to hear Mandi discuss:

  • how talking about her surgery with her sister was both emotional and freeing
  • how it felt to see her reconstructive surgeon again after she was completely healed
  • how her sister’s experience helped guide her
  • why family support is so important

Running time: 9:02

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Stories of Genetic Testing, Prophylactic Surgery, and Reconstruction: Kerry Kerry Osmond

September 8, 2016

Kerry headshot

Kerry Osmond was 10 when her mother was diagnosed with breast cancer in 1990. When it became available, genetic testing for a mutation that raises the risk of breast cancer was strongly recommended for Kerry’s mom -- in 2010 her mother tested positive for a BRCA2 mutation. Kerry knew that meant she had a 50-50 chance of having the same mutation. In 2012, she decided to have genetic testing and learned that she, too, had a BRCA2 mutation. She decided to have a double prophylactic mastectomy and reconstruction using tissue from her hip area. Kerry is one of three women whose stories are featured in the Breastcancer.org video series on genetic testing, prophylactic surgery, and reconstruction. Kerry’s younger sister, Mandi, also tested positive for a BRCA2 mutation and is also in the video series.

Listen to the podcast to hear Kerry talk about:

  • how her family uses their experience to help others
  • how she connected with women who had similar surgeries on the Breastcancer.org discussion boards
  • how sharing her story in the video was healing in a way
  • why talking to other women who had already had prophylactic surgery was encouraging

Running time: 13:56

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Stories of Genetic Testing, Prophylactic Surgery, and Reconstruction: Lorell Lorell Hornbrook

September 6, 2016

Lorell headshot

Lorell Hornbrook has a strong family history of breast cancer: Both her older sister and her father were diagnosed with breast cancer. Her father died at age 75 from treatment complications, a year after he was diagnosed. In 2014, at age 48, Lorell decided to have genetic testing to see if she had a gene mutation that dramatically increased her risk for breast cancer. When her test results came back positive for a BRCA2 mutation, Lorell had already decided what she would do: a double prophylactic mastectomy and reconstruction using tissue from her tummy area. Lorell is one of three women whose stories are featured in the Breastcancer.org video series on genetic testing, prophylactic surgery, and reconstruction.

Listen to the podcast to hear Lorell talk about:

  • why she never hesitated about participating in the videos
  • the type of research she did after she got her genetic test results
  • how she prepared herself for surgery
  • the advice she would give to women in a similar situation

Running time: 11:04

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Prophylactic Surgery for Women at High Risk: Part 2 Alan Stolier, M.D., F.A.C.S.

May 18, 2016

Stolier alan cropped

Dr. Alan Stolier is a surgeon at the Center for Restorative Breast Surgery in New Orleans. He has more than 35 years of experience in surgical oncology. He specializes in the surgical treatment of breast cancer and is a pioneer in the development of nipple-sparing mastectomy. Dr. Stolier also focuses on breast cancer genetics and the associated care of women who have a BRCA gene mutation.

Listen to the podcast to hear Dr. Stolier talk about:

  • the timing of prophylactic surgery
  • other genetic mutations besides BRCA1 or BRCA2 that might make a woman consider prophylactic surgery
  • the type of screening program recommended for a woman who’s had prophylactic surgery
  • how often cancer is found during prophylactic surgery

Running time: 24:13

Listen to part 1 of the series.

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Prophylactic Surgery for Women at High Risk: Part 1 Alan Stolier, M.D., F.A.C.S.

May 11, 2016

Stolier alan cropped

Dr. Alan Stolier is a surgeon at the Center for Restorative Breast Surgery in New Orleans. He has more than 35 years of experience in surgical oncology. He specializes in the surgical treatment of breast cancer and is a pioneer in the development of nipple-sparing mastectomy. Dr. Stolier also focuses on breast cancer genetics and the associated care of women who have a BRCA gene mutation.

Listen to the podcast to hear Dr. Stolier talk about:

  • how much each type of prophylactic surgery (breast, ovaries, fallopian tubes, uterus) can reduce risk
  • who is most likely to benefit from prophylactic surgery
  • women who shouldn’t consider prophylactic surgery
  • whether there is an optimal age for prophylactic surgery

Running time: 27:01

Listen to part 2 of the series.

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Genetics, Genetic Testing, and Breast Cancer: Part 3 Cristina Nixon, M.S., L/CGC

May 4, 2016

Cristina nixon   8859

Cristina Nixon is a licensed certified genetic counselor with the Cancer Risk Assessment and Genetics Program at Main Line Health in Pennsylvania. In addition to counseling patients, she also assists with research, including most recently a study looking at multi-gene panels in BRCA1/BRCA2-positive families. Cristina also has completed the City of Hope’s intensive course in cancer risk assessment.

This is part three of three-part podcast on genetics and breast cancer with Cristina. Listen to this podcast to hear her explain:

  • how a woman could use an online risk assessment tool
  • the factors the different tools consider
  • why it’s important that a woman use a risk assessment tool with her doctor or a licensed genetic counselor
  • what the results from direct-to-consumer testing companies such as 23andMe and Ancestry.com contain

Running time: 11:37

Listen to part 1 of the series.

Listen to part 2 of the series.

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Genetics, Genetic Testing, and Breast Cancer: Part 2 Cristina Nixon, M.S., L/CGC

April 27, 2016

Cristina nixon   8859

Cristina Nixon is a licensed certified genetic counselor with the Cancer Risk Assessment and Genetics Program at Main Line Health in Pennsylvania. In addition to counseling patients, she also assists with research, including most recently a study looking at multi-gene panels in BRCA1/BRCA2-positive families. Cristina also has completed the City of Hope’s intensive course in cancer risk assessment.

This is part two of three-part podcast on genetics and breast cancer with Cristina. Listen to this podcast to hear her explain:

  • the factors that would recommend genetic testing for a particular woman
  • whether DCIS is considered differently than invasive cancer when recommending genetic testing
  • the process of genetic testing
  • when genetic testing wouldn’t be recommended for a woman diagnosed with breast cancer

Running time: 23:44

Listen to part 1 of the series.

Listen to part 3 of the series.

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Genetics, Genetic Testing, and Breast Cancer: Part 1 Cristina Nixon, M.S., L/CGC

April 20, 2016

Cristina nixon   8859

Cristina Nixon is a licensed certified genetic counselor with the Cancer Risk Assessment and Genetics Program at Main Line Health in Pennsylvania. In addition to counseling patients, she also assists with research, including, most recently, a study looking at multi-gene panels in BRCA1/BRCA2 positive families. Cristina also has completed the City of Hope’s intensive course in cancer risk assessment.

This is part one of three-part podcast on genetics and breast cancer with Cristina. Listen to this podcast to hear her explain:

  • the difference between a genetic abnormality and a genetic mutation
  • what the BRCA1 and BRCA2 genes do in the body and why having a mutation in one of them increases the risk of breast cancer
  • other genes besides the BRCA genes that are linked to a higher risk of breast cancer
  • other types of cancer that are linked to a BRCA1 or BRCA2 mutation

Running time: 20:55

Listen to part 2 of the series.

Listen to part 3 of the series.

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Does Chemotherapy Increase the Risk of Common Infections? Brian Wojciechowski, M.D.

February 10, 2016

Brian wojciechowski md final  6340

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org’s medical adviser, explains a study published in January 2016 suggesting that chemotherapy for breast cancer may increase the risk of common infections.

Listen to the podcast to hear Dr. Wojciechowski talk about:

  • how the immune system works
  • how chemotherapy affects the immune system
  • when women who will be undergoing chemotherapy should get vaccines
  • steps you can take to support your immune system

Running time: 11:03

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Supporting a Partner With Breast Cancer Courtney Bitz, MSW, LCSW

February 9, 2016

Courtney bitz 150x180

Courtney Bitz is a licensed clinical social worker who heads the Couples Coping with Cancer Together program for City of Hope, a comprehensive cancer center in Duarte, Calif. When a woman is diagnosed with breast cancer, research has shown that having a supportive partner is one of the most important factors in helping her cope. But partners may struggle with knowing what to say or how best to support a loved one. The only program of its kind, Couples Coping with Cancer Together helps women and their partners identify problems that are most important to them as part of their overall medical care.

Listen to the podcast to hear Courtney discuss:

  • how the Couples Coping with Cancer Together program works
  • specific examples of how a woman can ask for and get the support she needs
  • the different ways women and men cope with stress and how each can understand the other better
  • common requests that women who have been diagnosed with breast cancer ask of their partners

Running time: 27:25

To help our visitors, Courtney provided the Partners’ Guide to Managing the Challenges of Breast Cancer (download the PDF). It offers tips on what partners can do to help a woman who’s been diagnosed, as well as tips for what diagnosed women can do to get the best support from their partners and other loved ones.

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Diet, Obesity, and Breast Cancer Tracy Crane, R.D.

February 4, 2016

Tracy crane  headshot %282%29

Tracy Crane is a registered dietitian and senior research specialist at the University of Arizona Zuckerman College of Public Health. Her research focuses on diet, specifically studying diet quality and cancer risk. Tracy also has more than 15 years’ experience developing nutrition plans for cancer survivors, many of them breast cancer survivors.

Listen to the podcast to hear Tracy discuss:

  • why obesity is linked to higher breast cancer risk
  • the new U.S. Department of Agriculture 2015-2020 Dietary Guidelines for Americans and what they mean for women who’ve been diagnosed with breast cancer, as well as women who want to keep their risk of the disease as low as it can be
  • how to make lasting changes to your diet
  • styles of eating that can keep your risk of breast cancer or breast cancer recurrence as low as it can be

Running time: 21:25

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

All About Cold Caps Hope Rugo, M.D.

January 25, 2016

Rugo hope2

Hope Rugo, M.D. is a medical oncologist specializing in breast cancer research and treatment. A professor of medicine at the University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, Dr. Rugo is the director of the Breast Oncology Clinical Trials Program and is the lead researcher on a number of studies investigating new treatments for both early-stage and metastatic breast cancer. Dr. Rugo is a member of the Breastcancer.org Professional Advisory Board. She also was the lead researcher on the study that led to the U.S. Food and Drug Administration approval of the DigniCap, a cold cap that may help some women keep some or quite a bit of hair during chemotherapy. Listen to the podcast to hear Dr. Rugo explain:

  • how she became interested in studying cold caps
  • how cold caps work
  • her research on the DigniCap
  • how much cold caps might cost and whether insurance is covering it yet

Running time: 20:32

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Precision Medicine and the “Moonshot” Program Nancy Davidson, M.D.

January 21, 2016

Davidson nancy

Nancy Davidson, M.D., is director of the University of Pittsburgh Cancer Institute, where she also is a distinguished professor of medicine and associate vice chancellor for cancer research. She also serves as president-elect of the American Association for Cancer Research, the first and largest cancer research organization in the world. Dr. Davidson is a world-renowned breast cancer researcher who has played a key role in discovering how hormones, particularly estrogen, affect cell growth in breast cancer. Listen to the podcast to hear Dr. Davidson explain:

  • what the American Association for Cancer Research is and what its goals are
  • what precision medicine is
  • what she thinks the moonshot program to conquer cancer will do
  • what new treatments she sees coming in the near future

Running time: 11:25

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

2015 San Antonio Breast Cancer Symposium: Lumpectomy Plus Radiation vs. Mastectomy for Early-Stage Disease Marisa Weiss, M.D.

December 15, 2015

Marisa blog thumb

In this Breastcancer.org podcast, Marisa Weiss, M.D., Breastcancer.org’s chief medical officer, discusses a study examining survival rates after lumpectomy plus radiation or mastectomy for early-stage breast cancer. The study was presented at the 2015 San Antonio Breast Cancer Symposium Dec. 8-12. Listen to the podcast to hear Dr. Weiss explain:

  • why lumpectomy plus radiation and mastectomy are both good choices for early-stage breast cancer surgery
  • why one type of surgery might be recommended over the other
  • why the researchers think there might have been a difference in survival rates

Running time: 11:27

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

2015 San Antonio Breast Cancer Symposium: Arimidex, Tamoxifen, and Recurrence Risk After DCIS Marisa Weiss, M.D.

December 15, 2015

Marisa blog thumb

In this podcast, Marisa Weiss, M.D., Breastcancer.org’s chief medical officer, explains a study that looked at the effectiveness of Arimidex and tamoxifen for reducing risk after DCIS surgery and radiation, as well as the side effects of each medicine. The study was presented at the 2015 San Antonio Breast Cancer Symposium, December 8-12. Listen to the podcast to hear Dr. Weiss explain:

  • what DCIS is
  • why postmenopausal women should be reassured no matter which of these medicines they’re taking
  • the side effects of each medicine

Running time: 11:26

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Research Highlights From the 2015 San Antonio Breast Cancer Symposium Brian Wojciechowski, M.D.

December 14, 2015

Brian wojciechowski md final  6340

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org’s medical adviser, talks about four studies that were presented at the 2015 San Antonio Breast Cancer Symposium, December 8-12, including studies that offer encouraging news about treatment for women diagnosed with triple-negative disease and metastatic, HER2-positive breast cancer. Listen to the podcast to hear Dr. Wojciechowski explain:

  • what luminal A breast cancer is and why women diagnosed with this subtype didn’t seem to benefit from chemotherapy after surgery
  • why adding carboplatin to a standard chemotherapy before surgery for triple-negative breast cancer improved pathologic complete response rates and what this means for women with triple-negative disease
  • why postmenopausal women diagnosed with early-stage, hormone-receptor-positive breast cancer who are taking an aromatase inhibitor and have experienced bone loss might want to consider taking the targeted therapy denosumab
  • results showing that Kadcyla improves overall survival in women diagnosed with metastatic, HER2-positive breast cancer that has stopped responding to Herceptin and Tykerb

Running time: 18:51

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Aniela McGuinness: Choosing to Laugh at What Life Gives Her

October 29, 2015

This Breastcancer.org podcast features Aniela McGuinness, an actress and the creator of the My Breast Choice blog. Aniela knew she had an abnormal BRCA1 gene and lost her mother to ovarian cancer in 2013. A year and a half later, at age 31, Aniela was diagnosed with stage I breast cancer, three days before her appointment to schedule a preventive double mastectomy.

Listen to the podcast to here Aniela talk about:

  • why she decided to create her blog and YouTube channel
  • how she uses humor to get cope with things that upset her
  • how she came with the idea for her mastectomy photo series
  • her Halloween costume and why Halloween is the best holiday for people with cancer

Running time: 21:19

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Marie Arsenault, Metastatic Patient, Talks About the Need for a Cure, Not Awareness

October 2, 2015

This Breastcancer.org podcast features Marie Arsenault, a former music promoter and booking agent, who was first diagnosed with stage II estrogen-receptor-positive, HER2-negative breast cancer in September 2000 at age 36. She had mastectomy with TRAM flap reconstruction, chemotherapy, and radiation. In May 2007, she was diagnosed with metastatic disease; the breast cancer had returned in her liver and bones. In 2011, the cancer spread to her bone marrow.

Listen to the podcast to hear Marie talk about:

  • how she feels during Breast Cancer Awareness Month
  • what she would like people to know about metastatic breast cancer
  • how her support network helps her stay positive through treatment
  • her volunteer work with the Tenth Life Cat Rescue in St. Louis

Running time: 22:06

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Holley Kitchen, "Cancer Lifer," Talks Metastatic Disease and Her Viral Video

June 12, 2015

This Breastcancer.org podcast features Holley Kitchen, the metastatic “cancer lifer” as she calls herself, whose June 4, 2015 video about what it’s like to live with metastatic breast cancer went viral on Facebook and other media outlets. Holley was diagnosed with stage III breast cancer in 2012. In 2013, she learned that the cancer had recurred in her spine and other bones.

Listen to the podcast to hear Holley talk about:

  • why and how she made her now-famous video
  • her support group of other younger women with metastatic disease and why it’s so important to her
  • some of the most common misconceptions about metastatic disease
  • what she’s doing next

Running time: 27:04

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

March 2015 Research Highlights Brian Wojciechowski, M.D.

March 26, 2015

Brian wojciechowski md final  6340

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org’s medical adviser, discusses a study looking at whether Zoladex (chemical name: goserelin) given during chemotherapy can help preserve fertility in premenopausal women diagnosed with early-stage, hormone-receptor-negative breast cancer. Listen to the podcast to hear Dr. Wojciechowski explain:

  • when Zoladex is given
  • why women shouldn’t get pregnant while they’re being treated with chemotherapy and Zoladex
  • why a woman might have to bring this treatment up with her doctor
  • why this treatment is only recommended for women diagnosed with early-stage, hormone-receptor-negative disease

Running time: 9:33

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

February 2015 Research Highlights Brian Wojciechowski, M.D.

February 19, 2015

Brian wojciechowski md final  6340

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org’s medical adviser, discusses Ibrance, a medicine that was approved to treat metastatic, hormone-receptor-positive breast cancer in February 2015. Listen to the podcast to hear Dr. Wojciechowski explain:

  • how Ibrance works
  • who is eligible to take Ibrance
  • how Ibrance is taken and whether any other medicines are taken with it
  • the side effects that Ibrance can cause

Running time: 9:55

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

How Breast Cancer Treatment Affects Your Ability to Exercise

February 6, 2015

In this Breastcancer.org podcast, Kathy Miller, M.D., talks about how breast cancer treatments can affect your stamina and your ability to exercise, as well as how to exercise during treatment. Dr. Miller is a professor of medicine at Indiana University and is the author of more than 60 scientific papers, many of which focus on breast cancer biology and treatment. Dr. Miller also is a member of the Breastcancer.org Professional Advisory Board.

Listen to the podcast to hear Dr. Miller talk about:

  • how to figure out what a safe level of exercise is while you’re getting chemotherapy or radiation or recovering from surgery
  • tips on how to start exercising if you’ve never exercised before
  • how treatment can change your stamina
  • the benefits of exercise, including helping women recover from treatment

Running time: 21:21

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Healthy Eating During the Holidays

December 15, 2014

In this Breastcancer.org podcast, Diana Dyer, R.D. talks about how to eat healthy before, during and after the holidays. Diana is a registered dietitian and multiple-time cancer survivor. She the author of the book A Dietitian’s Cancer Story and writes the blog DianaDyer.com, where she shares her thoughts about life as a cancer survivor, food and nutrition, growing food, recipes, and our environment. Diana also is a member of the Breastcancer.org Professional Advisory Board.

Listen to the podcast to hear Diana talk about:

  • strategies for coping with the snack table at holiday parties
  • how to be festive and alcohol-free
  • tips for eating if you’re undergoing chemo during the holidays
  • ideas for making traditional family dishes healthier

Running time: 24:12

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

2014 San Antonio Breast Cancer Symposium Research Highlights Brian Wojciechowski, M.D.

December 12, 2014

Brian wojciechowski md final  6340

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org medical adviser, discusses some of the research that was presented at the 2014 San Antonio Breast Cancer Symposium. Listen to the podcast to hear Dr. Wojciechowski explain:

  • results of a study that found that Aromasin plus ovarian suppression reduced recurrence risk better than tamoxifen plus ovarian suppression in some women diagnosed with early-stage, hormone-receptor-positive disease
  • research that underscored the long-term benefits of tamoxifen for reducing risk in women with a higher-than-average risk of breast cancer who’ve never been diagnosed
  • a study showing that Faslodex worked better than Arimidex as a first treatment for women newly diagnosed with advanced-stage breast cancer
  • research conducted in part by Breastcancer.org that shows that breastfeeding, even for a short time, reduces breast cancer risk more than previously thought
  • why a low-fat diet improved survival in women diagnosed with hormone-receptor-negative breast cancer

Running time: 16:01

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

November 2014 Research Highlights Brian Wojciechowski, M.D.

December 5, 2014

Brian wojciechowski md final  6340

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org medical adviser, discusses some of the research that was published in November 2014. Listen to the podcast to hear Dr. Wojciechowski explain:

  • results of a study that found calcium channel blockers, a common type of high blood pressure medicine, don’t increase breast cancer risk
  • new guidelines from the Society for Integrative Oncology on complementary therapies for breast cancer
  • why more U.S. women are choosing mastectomy over lumpectomy to remove early-stage breast cancer
  • how the experimental targeted therapy olaparib works and why it may work against advanced-stage cancers in people with an abnormal BRCA1 or BRCA2 gene

Running time: 17:13

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Male Breast Cancer Diagnosis and Awareness

November 24, 2014

In this Breastcancer.org podcast, Harvey Singer talks about his diagnosis of breast cancer and awareness of male breast cancer in general, especially during October. With his sister Vicki Singer Wolf, a three-time breast cancer survivor, Harvey is the founder of the HISBreastCancer Awareness, Inc. Foundation and HISBreastCancer.org. He also wrote the book Sir, You Have Breast Cancer! My Life and the Story of a Man with a Woman’s Disease.

Listen to the podcast to hear Harvey talk about:

  • the shock of his diagnosis
  • how he made his treatment decisions
  • how perceptions of male breast cancer have changed
  • risk reduction advice he recommends for men at high risk

Running time: 36:27

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

October 2014 Research Highlights Brian Wojciechowski, M.D.

November 3, 2014

Brian wojciechowski md final  6340

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org medical adviser, discusses some of the research that was published in October 2014. Listen to the podcast to hear Dr. Wojciechowski explain:

  • results of a study that found the targeted therapy Herceptin offers long-lasting benefits for women diagnosed with early-stage HER2-positive disease
  • a study that found occult cancers in more than 2% of women who were having their ovaries removed preventively because of genetics or family history
  • why Hispanic women still need to take steps to reduce their risk of breast cancer, even if they have a genetic variant that may lower their risk
  • why more research is needed before a new genomic test can be used to make treatment decisions

Running time: 13:40

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Hope After a Triple-Negative Breast Cancer Diagnosis

October 23, 2014

In this Breastcancer.org podcast, Pat Prijatel talks about triple-negative breast cancer and what makes it different from other types of breast cancer. Pat Prijatel writes the blog Positives About Negative and is the author of Surviving Triple Negative Breast Cancer. She has been a magazine writer, editor, consultant, and professor for more than 35 years. She headed Drake University's magazine sequence for 22 years before taking over as director of the School of Journalism and Mass Communication in 2004. In May 2006, Pat was diagnosed with early-stage triple-negative breast cancer. She retired from Drake in 2007 to focus on health writing and her health. She had surgery, chemotherapy, and radiation, and is now healthy, fit, and cancer-free.

Listen to the podcast to hear Pat talk about:

  • what the idea of triple-negative disease meant to her when she was diagnosed
  • when and why she started her blog
  • what researchers have learned recently about triple-negative disease
  • advice she would give to a woman newly diagnosed with triple-negative breast cancer

Running time: 22:57

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

September and October 2014 Research Highlights Brian Wojciechowski, M.D.

October 6, 2014

Brian wojciechowski md final  6340

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org medical adviser, discusses some of the research that was published in September and October 2014. Listen to the podcast to hear Dr. Wojciechowski explain:

  • results of a study that found the targeted therapy Perjeta increased overall survival by about 1.5 years in women diagnosed with HER2-positive metastatic breast cancer
  • why wearing a bra IS NOT linked to breast cancer risk
  • why breastfeeding decreases breast cancer risk
  • how Trelstar might increase the chances that some premenopausal women get pregnant after going through breast cancer treatment

Running time: 18:03

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Breast Reconstruction Techniques and Revisions Frank DellaCroce, M.D., F.A.C.S.

October 1, 2014

Dellacroce suit

This Breastcancer.org podcast focuses on breast reconstruction and features Frank DellaCroce, M.D., F.A.C.S., cofounder of the Center for Restorative Breast Surgery and the St. Charles Surgical Hospital. Dr. DellaCroce is board certified in plastic and reconstructive surgery, and his pioneering work in microsurgery has made the Center for Restorative Breast Surgery an international leader in the art and science of breast reconstruction. He has performed thousands of breast reconstructions on women from around the world. Listen to the podcast to hear Dr. DellaCroce discuss:

  • the advances in reconstruction that have happened in the past decade
  • what microsurgery is and why it’s so specialized
  • the most popular breast reconstruction options
  • how he assesses a breast reconstruction that a woman is unhappy with

Running time: 34:52

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Integrating Complementary Therapies Into Your Care Beth Baughman DuPree, M.D., F.A.C.S., A.B.I.H.M.

September 22, 2014

Beth dupree

Beth Baughman DuPree, M.D., F.A.C.S., A.B.I.H.M., is a general surgeon and also medical director of the Breast Health Program at the Holy Redeemer Health System, as well as an adjunct assistant professor of surgery for the University of Pennsylvania. Dr. DuPree strongly urges her patients to consider complementary healing support, whether it's through lifestyle modification, spiritual assistance, grief counseling, exercise programs, reflexology, nutritional counseling, Reiki, yoga, or massage. She herself has participated in all these techniques and is a master level Reiki practitioner. She believes that "whatever it takes to help a person find healing and peace is the way to curing them."

Listen to the podcast to hear Dr. DuPree talk about:

  • how she became interested in complementary therapies and how she integrates them into her practice
  • the healing benefits of some complementary therapies
  • how it feels to see her patients heal their minds and psyches as well as their bodies

Running time: 33:42

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Choosing to Live Breast Free

September 11, 2014

This Breastcancer.org podcast focuses on not having reconstruction after mastectomy and features Barbara Kriss, the founder of BreastFree.org, a nonprofit website that presents non-reconstruction as a positive alternative to reconstruction. Listen to the podcast to hear Barbara talk about:

  • how she made her decision to not have reconstruction
  • how to handle any pressure to have reconstruction from doctors or loved ones
  • how to ask your doctor for the best possible cosmetic results after mastectomy if you're not going to have reconstruction
  • clothing tips for women who opt for no reconstruction and decide not to wear breast forms

Running time: 25:49

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

August and September 2014 Research Highlights Brian Wojciechowski, M.D.

September 4, 2014

Brian wojciechowski md final  6340

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org medical adviser, discusses some of the research that was published in August and September 2014. Listen to the podcast to hear Dr. Wojciechowski explain:

  • results of a study that found an abnormal PALB2 gene increases breast cancer risk more than previously thought
  • why bisphosphonates don’t reduce risk in women who’ve never been diagnosed with breast cancer
  • the risk-reducing benefits of exercise for postmenopausal women
  • the risks and benefits of double mastectomy versus lumpectomy plus radiation for women at average risk diagnosed with breast cancer in just one breast

Running time: 19:34

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Living With Metastatic Breast Cancer

August 7, 2014

This Breastcancer.org podcast focuses on metastatic disease and features Roz Kleban, a licensed clinical social worker who is a clinical supervisor and program coordinator at the Breast Imaging Center at Memorial Sloan Kettering Cancer Center. Roz has worked at Memorial Sloan Kettering since 1989 and works with patients being treated for all stages of breast cancer. Listen to the podcast to hear Roz talk about:

  • why metastatic disease doesn't mean the loss of hope
  • how people with metastatic disease who feel isolated can build a community of people who understand what they're going through
  • how the needs of a woman with metastatic disease are different from the needs of a woman with early-stage disease

Running time: 24:00

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

How Breast Cancer Drugs Are Developed

July 18, 2014

In this Breastcancer.org podcast, Suzanne Wardell, Ph.D., talks about how breast cancer drugs are developed and why some drugs never make it to market. Dr. Wardell is a research scientist at Duke University in North Carolina. Her research interests lie in understanding the processes by which breast cancers develop resistance to tamoxifen and aromatase inhibitors and in developing drugs that will target estrogen receptor activity in these resistant tumors. Listen to the podcast to hear Dr. Wardell talk about:

  • bazedoxifene (BZA), a SERM approved in Europe to treat osteoporosis that has been shown to stop the growth of hormone-receptor-positive breast cancer cells
  • the importance of clinical trials
  • new research she's conducting suggesting that women diagnosed with breast cancer who do some form of moderate exercise three times a week while in treatment have better outcomes than women who don’t exercise; this applies to women who didn't exercise before being diagnosed, as well as women who did

Running time: 28:09

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

July 2014 Research Highlights Brian Wojciechowski, M.D.

July 17, 2014

Brian wojciechowski md final  6340

In this podcast, Brian Wojciechowski, M.D., Breastcancer.org medical adviser, discusses some of the research that was published in July 2014. Listen to the podcast to hear Dr. Wojciechowski talk about:

  • why treating inflammatory breast cancer with three treatments -- chemotherapy, surgery, and radiation -- improves survival compared to using only one or two of these treatments
  • the reasons why having more moles is linked to a higher risk of breast cancer, though moles themselves DO NOT cause breast cancer
  • research showing that women with an abnormal BRCA1 gene -- but not an abnormal BRCA2 gene -- diagnosed with breast cancer are more likely to survive if they have their ovaries and fallopian tubes removed
  • a study that found combining 3-D mammograms (digital tomosynthesis) and digital mammograms find more breast cancers with fewer false positives

Running time: 20:50

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

May and June 2014 Research Highlights Brian Wojciechowski, M.D.

June 13, 2014

Brian wojciechowski md final  6340

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org medical adviser, discusses some of the research that was published in May 2014 or presented at the American Society of Clinical Oncology Annual Meeting in June 2014. Listen to the podcast to hear Dr. Wojciechowski explain:

  • why using Aromasin on top of ovarian suppression medicine is better at reducing risk in premenopausal women than tamoxifen on top of ovarian suppression medicine
  • why some research studies on any links between vitamin D and breast cancer outcomes seem to have mixed results
  • the American Society of Clinical Oncology special series of articles on pain in people diagnosed with cancer
  • why childhood cancer survivors have a higher risk of breast cancer, even if they didn’t have radiation to the chest area

Running time: 21:44

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Sexuality and Breast Cancer: From Diagnosis to Survivorship

June 5, 2014

In this Breastcancer.org podcast, Michael Krychman, M.D. discusses female sexual health and how a breast cancer diagnosis and treatment can affect sexual function and quality of life. Dr. Krychman is executive director of the Southern California Center for Sexual Health and Survivorship Medicine, as well as a clinical sexologist. Dr. Krychman also is writing a new blog for Breastcancer.org called "Sex Matters." Listen to the podcast to hear Dr. Krychman talk about:

  • some of the biggest sexual issues and side effects during and after breast cancer treatment
  • the best way to discuss sexual issues with your doctor, especially if you're not comfortable with the topic
  • the importance of having an individualized survivorship care plan that includes a sexual health component

Running time: 27:15

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

April 2014 Research Highlights Brian Wojciechowski, M.D.

May 29, 2014

Brian wojciechowski md final  6340

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org’s medical adviser, discusses some of the most talked-about studies that came out in April 2014. Listen to the podcast to hear Dr. Wojciechowski explain:

  • the new American Association of Clinical Oncology (ASCO) guidelines on sentinel lymph node biopsy for people diagnosed with early-stage disease
  • more guidelines from ASCO on issues faced by survivors, including chemotherapy-induced neuropathy, fatigue, and depression
  • how healthy eating improves survival
  • why an individualized approach to mammography screening is needed

Running time: 27:02

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Writing and Healing After a Cancer Diagnosis

April 24, 2014

The second April 2014 Breastcancer.org podcast features Pamela Post-Ferrante, a four-time breast cancer survivor, writer, teacher, and workshop leader. She wrote her book, Writing and Healing: A Mindful Guide for Cancer Survivors, to help others use writing and mindfulness to heal themselves. Listen to the podcast to hear Pamela discuss:

  • how writing helped her heal
  • how the exercises in her book have helped others
  • why therapeutic writing is so powerful

Running time: 33:41

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

March 2014 Research Highlights Brian Wojciechowski, M.D.

April 10, 2014

Brian wojciechowski md final  6340

In the first April 2014 Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org's medical adviser, talks about some of the most interesting research studies that were published in March 2014. Listen to the podcast to hear Dr. Wojciechowski discuss:

  • the importance of exercise to reduce breast cancer risk
  • the new guidelines for the size of cancer tumor margins
  • available options for women who are having trouble paying for treatment
  • resources for older cancer survivors who might be having sexuality issues
  • how radiation after mastectomy benefits women with one to three positive lymph nodes
  • results from a phase II trial on the experimental medicine palbociclib

Running time: 31:20

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

How Pets Help Us Heal

March 27, 2014

The March 2014 Breastcancer.org podcast features Michele Pich, a psychologist and veterinary grief counselor at the University of Pennsylvania School of Veterinary Medicine. Michele also has extensive experience in leading support groups for people diagnosed with cancer. Michele brought along Vivian, her certified therapy dog who has been named Therapy Dog Ambassador for two years in a row at the National Dog Show. Listen to the podcast to hear Michele discuss:

  • the physical and psychological reasons pets are so comforting
  • how the therapy animal world has expanded beyond dogs
  • Michele and Vivian's experiences helping women diagnosed with breast cancer
  • how you can arrange for a visit from a certified therapy animal

Running time: 28:51

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

February 2014 Research Highlights Brian Wojciechowski, M.D.

March 3, 2014

Brian wojciechowski md final  6340

In the March 2014 Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org’s medical adviser, discusses some of the most talked about research studies that were published in February 2014. Listen to the podcast to hear Dr. Wojciechowski explain:

  • the Canadian mammogram study and why it’s flawed
  • why the FDA is warning women not to use ductal lavage in place of mammograms
  • the importance of starting chemotherapy within 30 days of surgery
  • how yoga can ease fatigue and reduce inflammation in women diagnosed with breast cancer
  • how acupuncture can ease aromatase inhibitor side effects

Running time: 23:01

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Sexuality and Breast Cancer: Get Your Mojo Back Lynn Wang, M.D.

February 12, 2014

Lynn wang 4.16

Because Valentine’s Day is in February, many people start thinking about romance, love, and sex -- and their satisfaction with what they have. The February 2014 Breastcancer.org podcast features Lynn Wang, M.D., female sexual medicine specialist for the Main Line Health System and member of the Breastcancer.org Professional Advisory Board. She is a board-certified gynecologist and American Association of Sexuality Educators, Counselors and Therapists-certified counselor and educator. Listen to the podcast to hear Dr. Wang discuss:

  • different models of female sexual response
  • the biological, psychological, social, and relationship reasons why libido may be reduced
  • how a breast cancer diagnosis and treatment can affect libido and sexual satisfaction
  • who to talk to if you’re having sexual problems

Running time: 29:54

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Research Highlights From the San Antonio Breast Cancer Symposium, December 13, 2013 Brian Wojciechowski, M.D.

December 13, 2013

Brian wojciechowski md final  6340

In this edition of our podcast coverage from the 2013 San Antonio Breast Cancer Symposium, we bring you the latest information from these areas of breast cancer research:

  • post-treatment psychosocial and physical issues
  • updates on chemotherapy in high-risk women, early and metastatic breast cancers, triple-negative breast cancers, and in women with high numbers of circulating tumor cells
  • a new design for clinical trials that may allow drugs to become available sooner
  • breast cancer incidence in women using hormonal treatments for infertility
  • a presentation on what women know about risk reduction versus how they put this knowledge into practice, from Breastcancer.org Chief Medical Officer Marisa Weiss, M.D.

Running time: 24:18

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Research Highlights From the San Antonio Breast Cancer Symposium, December 12, 2013 Brian Wojciechowski, M.D.

December 12, 2013

Brian wojciechowski md final  6340

Listen to the December 12 updates from the 2013 San Antonio Breast Cancer Symposium on today's podcast! In this edition, we fill you in on the latest research about Arimidex (chemical name: anastrazole) for reducing the risk of a primary breast cancer, sticking to your aromatase inhibitor regimen, strength training and aerobics for the relief of aromatase inhibitor-induced joint pain relief, and survival improvements with bisphosphonates after early breast cancer. Breastcancer.org medical adviser Brian Wojciechowski, M.D. and senior editor Jamie DePolo explain the latest news.

Running time: 27:16

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Research Highlights From the San Antonio Breast Cancer Symposium, December 11, 2013 Brian Wojciechowski, M.D.

December 11, 2013

Brian wojciechowski md final  6340

In our premiere podcast, we're excited to bring you a summary of the day's research highlights from the San Antonio Breast Cancer Symposium 2013! We discuss treatments before surgery for HER2-positive cancers, radiation after lumpectomy in women over age 65, and more. Breastcancer.org medical adviser Brian Wojciechowski, M.D. and senior editor Jamie DePolo explain the latest news.

Running time: 26:14

These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.


Was this article helpful? Yes / No

Bco internal cc1718 banner miniad final 2 1
Back to Top